Top Biotechnology Companies
As of April 2009 and ordered by market capitalization:
| Stock Ticker | Company Short Name | Market Capitalization | Stock Px | P/E Ratio | 1Y Return | 12M Revenue | 12M EPS |
| AMGN US Equity | AMGEN INC | 48,297,631,744 | 47.29 | 10.57 | -18% | 15,003,000,064 | 3.91 |
| GILD US Equity | GILEAD SCIENCES | 40,719,671,296 | 44.70 | 21.29 | -13% | 5,335,749,888 | 2.18 |
| CELG US Equity | CELGENE CORP | 18,732,310,528 | 40.77 | 29.76 | -26% | 2,254,780,992 | -3.74 |
| GENZ US Equity | GENZYME CORP | 15,532,229,632 | 57.24 | 17.45 | -14% | 4,605,039,232 | 1.56 |
| BIIB US Equity | BIOGEN IDEC INC | 15,516,600,320 | 52.20 | 14.84 | 10% | 4,097,506,880 | 2.68 |
| ATLN VX Equity | ACTELION LTD-REG | 5,756,683,776 | 46.13 | 19.21 | -12% | 1,362,169,817 | 2.52 |
| LIFE US Equity | LIFE TECHNOLOGIE | 5,676,325,888 | 32.66 | 11.40 | 40% | 1,620,322,944 | 0.61 |
| LONN VX Equity | LONZA GROUP -REG | 4,988,434,944 | 98.88 | 12.71 | 15% | 2,720,906,492 | 8.23 |
| NZYMB DC Equity | NOVOZYMES-B SHS | 4,560,102,912 | 70.16 | 22.57 | -6% | 1,607,726,917 | 3.40 |
| ILMN US Equity | ILLUMINA INC | 4,418,131,968 | 36.49 | 56.44 | 40% | 573,225,016 | 0.44 |
| VRTX US Equity | VERTEX PHARM | 4,313,058,816 | 28.34 | N.A. | -7% | 175,504,000 | -3.27 |
| MYGN US Equity | MYRIAD GENETICS | 4,085,115,904 | 43.64 | 37.14 | 32% | 386,647,000 | 1.08 |
| GRF SM Equity | GRIFOLS SA | 3,286,673,664 | 15.43 | 19.79 | -7% | 1,197,761,326 | 0.85 |
| QIA GR Equity | QIAGEN NV | 3,277,669,120 | 16.53 | 21.61 | -1% | 892,976,000 | 0.43 |
| ALXN US Equity | ALEXION PHARM | 3,064,390,912 | 37.51 | 100.03 | 4% | 259,099,000 | 0.43 |
| GPRO US Equity | GEN-PROBE | 2,436,275,968 | 46.55 | 23.87 | 9% | 472,695,000 | 1.99 |
| OSIP US Equity | OSI PHARMACEUTIC | 2,090,360,064 | 36.09 | 16.40 | -8% | 379,388,000 | 8.19 |
| TECH US Equity | TECHNE CORP | 2,077,665,024 | 55.42 | 19.65 | -14% | 268,491,000 | 2.82 |
| ABII US Equity | ABRAXIS BIOSCIEN | 1,908,173,952 | 47.62 | 148.81 | -28% | 345,309,000 | -6.91 |
| CRL US Equity | CHARLES RIVER LA | 1,851,412,992 | 27.72 | 9.77 | 6% | 1,343,492,960 | -7.82 |
| GEN DC Equity | GENMAB A/S | 1,775,739,520 | 39.56 | N.A. | 8% | 149,085,224 | -4.17 |
| UTHR US Equity | UNITED THERAPEUT | 1,743,709,952 | 65.96 | N.A. | 5% | 281,497,000 | -1.73 |
| ONXX US Equity | ONYX PHARM | 1,607,892,992 | 28.35 | 945.00 | -17% | 49,650,000 | 0.05 |
| ISIS US Equity | ISIS PHARM | 1,493,204,992 | 15.30 | N.A. | 8% | 116,178,998 | -0.13 |
| ICLL AV Equity | INTERCELL AG | 1,463,622,144 | 30.99 | 69.64 | 5% | 78,750,112 | 0.37 |
| AMLN US Equity | AMYLIN PHARM INC | 1,424,909,952 | 10.32 | N.A. | -5% | 840,108,976 | -2.31 |
| CRXL NA Equity | CRUCELL NV | 1,402,558,464 | 21.30 | 71.82 | 45% | 388,379,734 | 0.27 |
| 002007 CH Equity | HUALAN BIOLOGI-A | 1,359,090,560 | 6.04 | 48.54 | 7% | 68,159,148 | 0.12 |
| 068270 KS Equity | CELLTRION INC | 1,334,928,384 | 12.49 | 42.18 | 66% | 64,662,463 | 0.42 |
| CVTX US Equity | CV THERAPEUTICS | 1,280,188,032 | 19.93 | N.A. | 116% | 154,475,000 | -1.61 |
| 600161 CH Equity | BEIJING TIAN-A | 1,277,591,296 | 2.62 | 66.22 | 23% | 97,605,737 | 0.04 |
| DIA IM Equity | DIASORIN SPA | 1,245,180,160 | 22.64 | 24.55 | 18% | 359,797,181 | 1.01 |
| 002038 CH Equity | BEIJING SL -A | 1,229,076,736 | 4.95 | 38.55 | -8% | 50,882,694 | 0.13 |
| BMRN US Equity | BIOMARIN PHARMAC | 1,221,524,992 | 12.22 | 35.94 | -31% | 296,493,004 | 0.32 |
| REGN US Equity | REGENERON PHARM | 1,076,635,008 | 13.46 | N.A. | -27% | 238,457,000 | -1.05 |
| 002022 CH Equity | SHANGHAI KEHUA-A | 989,198,912 | 3.13 | 40.42 | -8% | 69,380,538 | 0.08 |
| CBST US Equity | CUBIST PHARM | 916,717,696 | 15.93 | 9.21 | -34% | 433,641,000 | 2.98 |
| SPPN SW Equity | SPEEDEL HOLD-REG | 889,948,800 | 113.89 | N.A. | 0% | 7,257,171 | -6.35 |
| SQNM US Equity | SEQUENOM INC | 867,099,520 | 14.22 | N.A. | -28% | 47,149,000 | -0.83 |
| PDLI US Equity | PDL BIOPHARMA IN | 852,742,720 | 7.14 | 8.40 | 24% | 315,226,000 | 0.57 |
| ALNY US Equity | ALNYLAM PHARMACE | 834,294,592 | 20.14 | N.A. | -19% | 96,163,000 | -0.64 |
| SGEN US Equity | SEATTLE GENETICS | 821,034,304 | 9.59 | N.A. | 7% | 35,236,001 | -1.07 |
| ACOR US Equity | ACORDA THERAPEUT | 784,958,528 | 20.78 | N.A. | 1% | 47,826,800 | -2.19 |
| LMNX US Equity | LUMINEX CORP | 757,716,672 | 18.27 | 261.00 | -14% | 104,447,000 | 0.07 |
| ITMN US Equity | INTERMUNE INC | 739,367,168 | 17.05 | N.A. | 61% | 48,152,001 | -2.51 |
| GHDX US Equity | GENOMIC HEALTH I | 731,218,432 | 25.65 | N.A. | 32% | 110,579,000 | -0.58 |
| 068870 KS Equity | LG LIFE SCIENCES | 718,833,920 | 43.36 | 63.30 | 43% | 261,132,563 | 0.84 |
| MEDX US Equity | MEDAREX INC | 681,080,576 | 5.30 | N.A. | -5% | 52,292,000 | -0.30 |
| CRA US Equity | CELERA CORP | 655,361,024 | 8.01 | N.A. | -28% | 169,009,000 | -1.39 |
| 002252 CH Equity | SHANGHAI RAAS -A | 631,280,128 | 3.95 | 35.95 | 7% | 44,539,960 | 0.11 |
| BIOS IN Equity | BIOCON LTD | 600,456,384 | 3.00 | 6.30 | 30% | 207,080,438 | 0.60 |
| BSLN SW Equity | BASILEA PHAR-REG | 585,167,808 | 61.14 | N.A. | -53% | 11,058,778 | -13.89 |
| JI4 GR Equity | JERINI AG | 570,649,344 | 9.68 | N.A. | 2% | 15,449,418 | -1.34 |
| EXEL US Equity | EXELIXIS INC | 522,338,400 | 4.91 | N.A. | -2% | 117,859,000 | -1.54 |
| BGC LN Equity | BTG PLC | 521,647,328 | 2.04 | N.A. | -1% | 113,431,046 | -0.02 |
| HALO US Equity | HALOZYME THERAPE | 515,097,504 | 6.21 | N.A. | 11% | 8,764,139 | -0.62 |
| 4974 JP Equity | TAKARA BIO INC | 508,799,584 | 1804.20 | 144.71 | 1% | 183,890,043 | 11.06 |
| ALTH US Equity | ALLOS THERAPEUT | 497,860,192 | 6.12 | N.A. | 0% | 0 | -0.68 |
| NKTR US Equity | NEKTAR THERAPEUT | 486,581,888 | 5.26 | N.A. | -5% | 90,184,000 | -0.37 |
| GNS LN Equity | GENUS PLC | 473,188,224 | 7.95 | 15.21 | -19% | 492,523,142 | 0.79 |